Prior Approval System
NHS England · awarded 2 December 2024
Who
| Buyer | NHS England Leeds |
|---|---|
| Supplier |
Blueteq Limited |
| Category | services |
| Classification | IT services: consulting, software development, Internet and support CPV 72000000 |
| Notice published | 23 December 2024 |
What it is for
A 12 months contract required for the NHS England prior approval system whilst conducting the Discovery and Alpha phases and procurement of the next iteration of the prior approval system. The NHS England prior approval system enables clinicians to prescribe high-cost medicines to patients promptly by confirming patient eligibility via an online form detailing clinical treatment criteria. The system is also used to ensure that NHS providers are reimbursed appropriately for the use if high-cost medicines. The Long-Term Plan describes the need to focus on quality, whilst driving efficiency and productive investment. It refers to unwarranted and unacceptable clinical variation, and the need to identify and eliminate such variation. It also refers to the need to exploit developments in information to accelerate improvements in care and improve transparency across organisations. The NHS England prior approval system supports this aim by ensuring that high-cost medicines are prescribed in accordance with NICE guidance and NHS England clinical policies.
Read the original award notice on Contracts Finder →
Other contracts from this buyer
1269 awards on file, worth £50.2bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 4 Mar 2026 | New Hospital Programme - Hospital 2.0 Alliance (H2A) FrameworkEngland | NHS England | Willmott Dixon Construction Limited +9 | £37.0bn |
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 1 Jul 2025 | NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Biogen +20 | £986.3m |
| 19 Dec 2024 | NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinScotland | NHS England | CSL Behring UK Ltd +5 | £905.2m |
| 31 May 2024 | NHS Framework - Blood Disorders including Haemophilia A and B - July 2024East Midlands | NHS England | Pfizer Ltd +8 | £765.0m |
Everything NHS England has awarded →
Other contracts won by this supplier
7 awards on file, worth £605k.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 23 Oct 2025 | Blueteq - Prior Approval System | NHS England | Blueteq Limited | £185k |
| 2 Dec 2024 | Prior Approval System | NHS England | Blueteq Limited | £185k |
| 15 Nov 2024 | 1784 Provision of an Electronic Patient Database for NHS Arden & GEM CSUEast Midlands | NHS Arden and Greater East Midlands… | Blueteq Limited | £127k |
| 7 Jan 2026 | IFR and PA Application SystemsSouth East | NHS SOUTH, CENTRAL AND WEST COMMISSIONING… | Blueteq Ltd | £42k |
| 18 Feb 2025 | G-Cloud 14England | NHS Midlands & Lancashire Commissioning… | BLUETEQ LTD | £35k |